Treatment of low-grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up

Haematologica

Volumn 86, Issue 6, 2001, Pages 609-617

  Montalban, C ^a   Santon, A ^a   Boixeda, D ^a   Redono, C ^a   Alvarez, I ^a   Calleja, J L ^a   De Argila, C M ^a   Bellas, C ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Gastric lymphoma; Lymphoma; MALT

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; ENDOSCOPY; ERADICATION THERAPY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; STOMACH BIOPSY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GENE REARRANGEMENT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES;

EID: 0034950510     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
2. Gastric lymphoid follicles in Helicobacter pylori infection: Frequency, distribution, and response to triple therapy
3. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori
4. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
5. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue
6. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
7. Diagnosis and posttreatment follow-up of Helicobacter pyloripositive gastric lymphoma of mucosa-associated lymphoid tissue: Histology, polymerase chain reaction, or both?
8. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: A study controlled by endoscopic ultrasonography
9. Helicobacter pylori eradication for the treatment of low grade gastric MALT lymphoma. Follow-up together with sequential molecular studies
10. Treatment of low grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response
11. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial
12. Antibiotic treatment for low-grade gastric MALT lymphoma
13. The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach
14. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of prognostic factors in 143 patients
15. Gastric MALT lymphoma: From concept to cure
16. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma
17. Evaluation of clonal immunoglobulin heavy chain rearrangements in Hodgkin's disease using the polymerase chain reaction (PCR)
18. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies
19. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: True relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy
20. Follow up of 120 patients with early low-grade gastric marginal zone B-cell lymphoma of MALT-type after Helicobacter pylori eradication therapy
21. Interim evaluation of gastric MALT lymphoma response to antibiotics in the ongoing LY03 randomised cooperative trial of observation vs. chlorambucil after anti-Helicobacter therapy
22. Most gastric low-grade B-cell lymphomas of mucosa-associated lymphoid tissue persist after Helicobacter pylori eradication
23. Predictive factors for regression of gastric MALT-lymphoma after anti-Helicobacter pylori treatment
24. Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors
25. Regression of MALT lymphoma following eradication after Helicobacter pylori is predicted by endosonographic staging
26. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection
27. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy
28. BCL1O gene mutation in lymphoma
29. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein
30. Helicobacter pylori genotypes may determine gastric histopathology
31. Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma
32. Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment
33. Long term B-cell monoclonality in gastric MALT lymphoma patients with complete histological remission after cure of H. pylori infection: Follow-up analysis of 97 patients and molecular studies on microdissected cells
34. PCR-based clonality analysis: A reliable method for the diagnosis and follow-up monitoring of conservatively treated gastric B-cell MALT lymphomas?
35. Ongoing somatic mutations and clonal expansions after cure of Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue B-cell lymphoma
36. Other cancers in patients with gastric MALT lymphoma
37. Incidence of second neoplasms in patients with MALT lymphoma: No increase in risk above the background population
38. Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: A clinicopathological study of 12 patients
39. Pathologic features of the gastric mucosa adjacent to primary MALT-lymphomas